200 related articles for article (PubMed ID: 28630652)
21. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
[TBL] [Abstract][Full Text] [Related]
22. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
[TBL] [Abstract][Full Text] [Related]
23. Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease.
Sakurai M; Takamura T; Ota T; Ando H; Akahori H; Kaji K; Sasaki M; Nakanuma Y; Miura K; Kaneko S
J Gastroenterol; 2007 Apr; 42(4):312-7. PubMed ID: 17464461
[TBL] [Abstract][Full Text] [Related]
24. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort.
De A; Keisham A; Mishra S; Mehta M; Verma N; Premkumar M; Taneja S; Das A; Singh V; Duseja A
J Clin Exp Hepatol; 2022; 12(2):440-447. PubMed ID: 35535068
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?
Daltro C; Cotrim HP; Alves E; de Freitas LA; Araújo L; Boente L; Leal R; Portugal T
Obes Surg; 2010 Nov; 20(11):1536-43. PubMed ID: 20556538
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
27. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
Chang EJ; Yi DY; Yang HR
J Korean Med Sci; 2015 Dec; 30(12):1821-7. PubMed ID: 26713058
[TBL] [Abstract][Full Text] [Related]
29. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
Kalavalapalli S; Leiva EG; Lomonaco R; Chi X; Shrestha S; Dillard R; Budd J; Romero JP; Li C; Bril F; Samraj G; Pennington J; Townsend P; Orlando F; Shetty S; Mansour L; Silva-Sombra LR; Bedossa P; Malaty J; Barb D; Gurka MJ; Cusi K
J Clin Endocrinol Metab; 2023 Apr; 108(5):1192-1201. PubMed ID: 36378995
[TBL] [Abstract][Full Text] [Related]
30. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
Koike K; Moriya K
J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
[TBL] [Abstract][Full Text] [Related]
31. Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.
Uraz S; Aygun C; Sonsuz A; Ozbay G
Dig Dis Sci; 2005 May; 50(5):964-9. PubMed ID: 15906776
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study.
Bedossa P; Moucari R; Chelbi E; Asselah T; Paradis V; Vidaud M; Cazals-Hatem D; Boyer N; Valla D; Marcellin P
Hepatology; 2007 Aug; 46(2):380-7. PubMed ID: 17659580
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis.
Cotler SJ; Kanji K; Keshavarzian A; Jensen DM; Jakate S
J Clin Gastroenterol; 2004 Oct; 38(9):801-4. PubMed ID: 15365409
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.
Siddiqui MS; Cheang KL; Luketic VA; Boyett S; Idowu MO; Patidar K; Puri P; Matherly S; Stravitz RT; Sterling RK; Sanyal AJ
Dig Dis Sci; 2015 Aug; 60(8):2529-37. PubMed ID: 25784075
[TBL] [Abstract][Full Text] [Related]
35. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
[TBL] [Abstract][Full Text] [Related]
36. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
[TBL] [Abstract][Full Text] [Related]
37. The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients.
Cetin EG; Demir N; Sen I
Sisli Etfal Hastan Tip Bul; 2020; 54(4):411-415. PubMed ID: 33364879
[TBL] [Abstract][Full Text] [Related]
38. Non-organ-specific autoantibodies in Indian patients with chronic liver disease.
Daschakraborty S; Aggarwal A; Aggarwal R
Indian J Gastroenterol; 2012 Sep; 31(5):237-42. PubMed ID: 22941677
[TBL] [Abstract][Full Text] [Related]
39. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
Nascimbeni F; Bedossa P; Fedchuk L; Pais R; Charlotte F; Lebray P; Poynard T; Ratziu V;
J Hepatol; 2020 May; 72(5):828-838. PubMed ID: 31862486
[TBL] [Abstract][Full Text] [Related]
40. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
